Cargando…

Effects of O‐methylated (−)‐epigallocatechin gallate (EGCG) on LPS‐induced osteoclastogenesis, bone resorption, and alveolar bone loss in mice

(−)‐Epigallocatechin‐3‐O‐gallate (EGCG), present in green tea, exhibits antioxidant and antiallergy effects. EGCG3″Me, a 3‐O‐methylated derivative of EGCG, has been reported to show similar biological functions; the inhibitory activity of EGCG3″Me in a mouse allergy model was more potent than that o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tominari, Tsukasa, Ichimaru, Ryota, Yoshinouchi, Shosei, Matsumoto, Chiho, Watanabe, Kenta, Hirata, Michiko, Grundler, Florian M.W., Inada, Masaki, Miyaura, Chisato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715342/ https://www.ncbi.nlm.nih.gov/pubmed/29226083 http://dx.doi.org/10.1002/2211-5463.12340

Ejemplares similares

Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced inflammatory bone resorption, and protects against alveolar bone loss in mice
por: Tominari, Tsukasa, et al.
Publicado: (2015)

Effects of Polymethoxyflavonoids on Bone Loss Induced by Estrogen Deficiency and by LPS-Dependent Inflammation in Mice
por: Matsumoto, Shigeru, et al.
Publicado: (2018)

Effects of 4′-Demethylnobiletin and 4′-Demethyltangeretin on Osteoclast Differentiation In Vitro and in a Mouse Model of Estrogen-Deficient Bone Resorption
por: Hirata, Michiko, et al.
Publicado: (2023)

Endosomal TLR3 signaling in stromal osteoblasts induces prostaglandin E(2)–mediated inflammatory periodontal bone resorption
por: Tominari, Tsukasa, et al.
Publicado: (2022)

Beta-Cryptoxanthin Inhibits Lipopolysaccharide-Induced Osteoclast Differentiation and Bone Resorption via the Suppression of Inhibitor of NF-κB Kinase Activity
por: Hirata, Narumi, et al.
Publicado: (2019)

Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption
por: Watanabe, Kenta, et al.
Publicado: (2017)

Capsaicin, a TRPV1 Ligand, Suppresses Bone Resorption by Inhibiting the Prostaglandin E Production of Osteoblasts, and Attenuates the Inflammatory Bone Loss Induced by Lipopolysaccharide
por: Kobayashi, Megumi, et al.
Publicado: (2012)

A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology
por: Tanaka, Ryo, et al.
Publicado: (2022)

Gram-positive bacteria cell wall-derived lipoteichoic acid induces inflammatory alveolar bone loss through prostaglandin E production in osteoblasts
por: Tominari, Tsukasa, et al.
Publicado: (2021)

Hypergravity and microgravity exhibited reversal effects on the bone and muscle mass in mice
por: Tominari, Tsukasa, et al.
Publicado: (2019)

Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
por: Singh, Neha Atulkumar, et al.
Publicado: (2016)

An Essential Role of Cytosolic Phospholipase A2α in Prostaglandin E2–mediated Bone Resorption Associated with Inflammation
por: Miyaura, Chisato, et al.
Publicado: (2003)

(−)-Epigallocatechin-3-Gallate (EGCG) Enhances Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells
por: Lin, Sung-Yen, et al.
Publicado: (2018)

Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
por: Zhong, Ying, et al.
Publicado: (2012)

Mechanism of (−)-epigallocatechin gallate (EGCG) dimerization by low-temperature plasma
por: Park, Seungil, et al.
Publicado: (2022)

Antibacterial Activity of Epigallocatechin Gallate (EGCG) against Shigella flexneri
por: Zhang, Yini, et al.
Publicado: (2023)

Characterization of the Synergistic Antioxidant Activity of Epigallocatechin Gallate (EGCG) and Kaempferol
por: Zhang, Qiang, et al.
Publicado: (2023)

Synthesis and Biological Testing of Novel Glucosylated Epigallocatechin Gallate (EGCG) Derivatives
por: Zhang, Xin, et al.
Publicado: (2016)

Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers
por: Huang, Yun-Ju, et al.
Publicado: (2020)

The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
por: Marín, Víctor, et al.
Publicado: (2023)

Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women
por: Siblini, Hiba, et al.
Publicado: (2023)

Cytoprotective Effect of Epigallocatechin Gallate (EGCG)-5′-O-α-Glucopyranoside, a Novel EGCG Derivative
por: Han, Sang Yun, et al.
Publicado: (2018)

The Combination of Soy Isoflavones and Resveratrol Preserve Bone Mineral Density in Hindlimb-Unloaded Mice
por: Tousen, Yuko, et al.
Publicado: (2020)

Monoalkylated Epigallocatechin-3-gallate (C18-EGCG) as Novel Lipophilic EGCG Derivative: Characterization and Antioxidant Evaluation
por: Minnelli, Cristina, et al.
Publicado: (2020)

Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises?
por: Mereles, Derliz, et al.
Publicado: (2011)

Epigallocatechin Gallate (EGCG) Is the Most Effective Cancer Chemopreventive Polyphenol in Green Tea
por: Du, Guang-Jian, et al.
Publicado: (2012)

Anti-Fatigue Effect of Green Tea Polyphenols (-)-Epigallocatechin-3-Gallate (EGCG)
por: Teng, Yu-song, et al.
Publicado: (2017)

Tea-induced improvement of endothelial function in humans: No role for epigallocatechin gallate (EGCG)
por: Lorenz, Mario, et al.
Publicado: (2017)

Green Tea Catechin (-)-Epigallocatechin-3-Gallate (EGCG) Facilitates Fracture Healing
por: Lin, Sung-Yen, et al.
Publicado: (2020)

In Vitro Evaluation of the Antiviral Activity of the Synthetic Epigallocatechin Gallate Analog-Epigallocatechin Gallate (EGCG) Palmitate against Porcine Reproductive and Respiratory Syndrome Virus
por: Zhao, Chunjian, et al.
Publicado: (2014)

Single Local Injection of Epigallocatechin Gallate-Modified Gelatin Attenuates Bone Resorption and Orthodontic Tooth Movement in Mice
por: Katsumata, Yuta, et al.
Publicado: (2018)

(−)-Epigallocatechin-3-Gallate Decreases Osteoclastogenesis via Modulation of RANKL and Osteoprotegrin
por: Chen, Shih-Tse, et al.
Publicado: (2019)

Regulation of Osteoclastogenesis and Bone Resorption by miRNAs
por: Inoue, Kazuki, et al.
Publicado: (2021)

Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells
por: Hazgui, Salma, et al.
Publicado: (2008)

Schedule-Dependent Effect of Epigallocatechin-3-Gallate (EGCG) with Paclitaxel on H460 Cells
por: Park, Sunghoon, et al.
Publicado: (2014)

Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG)
por: Chen, Hanyong, et al.
Publicado: (2015)

Molecular Targets of Epigallocatechin—Gallate (EGCG): A Special Focus on Signal Transduction and Cancer
por: Negri, Aide, et al.
Publicado: (2018)

Reciprocal Interactions between Epigallocatechin-3-gallate (EGCG) and Human Gut Microbiota In Vitro
por: Liu, Zhibin, et al.
Publicado: (2020)

The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review
por: Ferrari, Elena, et al.
Publicado: (2022)

Protective Effects of Epigallocatechin-3-gallate (EGCG) against the Jellyfish Nemopilema nomurai Envenoming
por: Li, Jie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_igpbt3ihq44gt0v7sineet0ded